SMS Pharmaceuticals Limited (NSE:SMSPHARMA)

SMS Pharmaceuticals Revenue

SMS Pharmaceuticals had revenue of 2.10B INR in the quarter ending December 31, 2025, with 21.40% growth. This brings the company's revenue in the last twelve months to 8.97B, up 14.96% year-over-year. In the fiscal year ending March 31, 2025, SMS Pharmaceuticals had annual revenue of 7.83B with 10.36% growth.

• Revenue (ttm): 8.97B
• Revenue Growth: +14.96%
• P/S Ratio: 3.84
• Revenue / Employee: 6.10M
• Employees: 1,470
• Market Cap: 34.42B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	7.83B	734.85M	10.36%
Mar 31, 2024	7.09B	1.87B	35.86%
Mar 31, 2023	5.22B	21.77M	0.42%
Mar 31, 2022	5.20B	-433.03M	-7.69%
Mar 31, 2021	5.63B	1.49B	35.93%